Advanced search
Publication Cover
Open Access Journal of Clinical Trials Volume 6, 2014 - Issue
Submit an article Journal homepage
65
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Safety and tolerability of an intravenously administered alpha1-proteinase inhibitor at an increased infusion rate: a novel, randomized, placebo-masked, infusion rate-controlled, crossover study in healthy adults

Leock Y NgoBaxter Healthcare Corporation, Westlake Village, CA, USA
,
Adam HaeberleBaxter Healthcare Corporation, Westlake Village, CA, USA
,
Jacqueline Dyck-JonesBaxter Healthcare Corporation, Westlake Village, CA, USA
,
David GelmontBaxter Healthcare Corporation, Westlake Village, CA, USA
&
Leman YelBaxter Healthcare Corporation, Westlake Village, CA, USACorrespondence[email protected]
Pages 55-61 | Published online: 23 Jun 2014

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.